Rocket withdraws FDA application for rare blood disorder gene therapy

Rocket Pharmaceuticals is withdrawing its FDA application for a gene therapy for Fanconi anemia, a rare genetic disease in which the bone marrow doesn’t make enough healthy blood cells. Rocket announced a ...